Maiwald
Lawyers at Maiwald and Sterne Kessler analyse how patents with claims directed to medical treatments are handled in the US and in Europe
Sponsored
Sponsored
-
Sponsored by MaiwaldThe handbook tackles the challenging task of making German life sciences patent law accessible to international practitioners. Xenia Boergen of Boergen Legal & Patents reviews an impressive undertaking by Marco Stief, Maximilian Haedicke, and Annelie Wünsche
-
Sponsored by MaiwaldThe EPO’s Enlarged Board of Appeal has confirmed that interveners in European Patent Convention appeal proceedings remain dependent parties and cannot continue proceedings after the withdrawal of all appeals, reports Johannes Scholz of Maiwald
-
Sponsored by MaiwaldKerstin Wolff of Maiwald explains how the EU’s provisional agreement on plants generated by new genomic techniques divides them into two categories, opening the market while preserving patent and regulatory oversight
-
Sponsored by MaiwaldSenior intellectual property practitioners from Maiwald discuss how innovators can secure robust patent protection for AI inventions amid evolving EPO practice and accelerating technological change
-
Sponsored by MaiwaldMarco Stief of Maiwald argues that the District Court of The Hague missed an opportunity to clarify the uncertainty surrounding the term ‘first authorisation’ in Article 3(d) of the SPC Regulation in a recent judgment
-
Sponsored by MaiwaldFabian Kiendl and Christian Schäflein of Maiwald examine how AI engineering can yield patentable inventions and consider the protection of such solutions in automotive technology under the European Patent Convention